
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum is well-positioned in the healthcare market as the company has strong growth potential and is continuously making strategic acquisitions to supplement its growth. The separation of the Health Information Systems segment will likely increase the company's value and eliminate the conglomerate discount. Additionally, the company has raised its guidance for organic growth, adjusted EPS, and free cash flow, and it remains committed to share repurchases and evaluating potential dividends.
Bears say
Solventum is facing challenges as they strive to unlock the conglomerate discount by separating their HIS business and focusing on their remaining segments. Despite progress in their transformation and exceeding expectations in their Q1 results, they are facing risks such as higher costs associated with TSA agreements and potential competition. With a lower growth profile and a current P/E multiple of 12.5x, their stock may not be as attractive compared to their peers who trade at a higher multiple.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares